The Clostridium difficile PCR ribotype 027 lineage: A pathogen on the move

Clinical Microbiology and Infection

Volumn 20, Issue 5, 2014, Pages 396-404

  Valiente, E ^a   Cairns, M D ^a,b,c   Wren, B W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; Dissemination; Evolution; Genome analysis; Pathogen; PCR RT 027

Indexed keywords

VIRULENCE FACTOR; ENTEROTOXIN;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CAMPYLOBACTER JEJUNI; CELL GROWTH; CLOSTRIDIUM DIFFICILE; DEVELOPED COUNTRY; IN VITRO STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENOMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; RIBOTYPING; SINGLE NUCLEOTIDE POLYMORPHISM; BACTERIAL GENOME; COMMUNICABLE DISEASE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULAR EVOLUTION; PATHOGENICITY; PEPTOCLOSTRIDIUM DIFFICILE; PHYLOGENY; PHYLOGEOGRAPHY;

ANIMALIA; CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

CLOSTRIDIUM DIFFICILE; COMMUNICABLE DISEASES, EMERGING; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; PHYLOGENY; PHYLOGEOGRAPHY; RIBOTYPING; VIRULENCE FACTORS;

EID: 84901587090     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12619     Document Type: Review

References (87)

1. Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 4(suppl): 265-272.
2. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-210.
3. Gerding DN. Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 2010; 31(suppl): 32-34.
4. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-415.
5. Barbut P, Gariazzo B, Bonne L et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007; 28: 131-139.
6. McGowan AP, Lalayiannis LC, Marshall B, Martin KE, Welfare MR. Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008. J Hosp Infect 2011; 77: 11-15.
7. Loo VG, Bourgault AM, Poirier L. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-1703.
8. Killgore G, Thompson A, Johnson S et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 2008; 46: 431-437.
9. Maiden MC. Multilocus sequence typing of bacteria. Annu Rev Microbiol 2006; 60: 561-588.
10. Lemee L, Bourgeois I, Ruffin E, Collignon A, Lemeland JF, Pons JL. Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekeeping genes of Clostridium difficile. Microbiology 2005; 151: 3171-3180.
11. Griffiths D, Fawley W, Kachrimanidou M et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 2010; 48: 770-778.
12. Dingle KE, Griffiths D, Didelot X et al. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 2011; 6: e19993.
13. Stabler RA, Dawson LF, Valiente E et al. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 2012; 7: e31559.
14. Stabler RA, Gerding DN, Songer JG et al. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 2006; 188: 7297-7305.
15. He M, Sebaihia M, Lawley TD et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci USA 2010; 107: 7527-7532.
16. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56: 2299-2306.
17. Razaq N, Sambol S, Nagaro K et al. Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J Infect Dis 2007; 196: 1813-1819.
18. Labbe AC, Poirier L, MacCannell D et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008; 52: 3180-3187.
19. Mooney H. Annual incidence of MRSA falls in England, but C. difficile continues to rise. BMJ 2007; 335: 958.
20. Kuijper EJ, Van den Berg RJ, Debast S et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006; 12: 827-830.
21. Kuijper EJ, Barbut F, Brazier JS et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008; 13(suppl 31): 18942.
22. O'Connor J, Johnson S, Gerding DN et al. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136: 1913-1924.
23. Kim J, Seo MR, Kang JO, Choi TY, Pai H. Clinical and microbiologic characteristics of Clostridium difficile infection caused by binary toxin producing strain in Korea. Infect Chemother 2013; 45: 175-183.
24. Cheng VC, Yam WC, Chan JF et al. Clostridium difficile ribotype 027 arrives in Hong Kong. Int J Antimicrob Agents 2009; 34: 492-493.
25. Lim PL, Ling ML, Lee HY et al. Isolation of the first three cases of Clostridium difficile polymerase chain reaction ribotype 027 in Singapore. Singapore Med J 2011; 52: 361-364.
26. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 2009; 190: 706-708
27. Quesada-Gomez C, Rodriguez C, Gamboa-Coronado M et al. Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 2010; 48: 669-670.
28. Roberts S, Heffernan H, Al Anbuky N et al. Epidemic strains of Clostridium difficile are present in Auckland, New Zealand. N Z Med J 2011; 124: 97-101.
29. Hernandez-Rocha C, Barra-Carrasco J, Pizarro-Guajardo M et al. Epidemic Clostridium difficile ribotype 027 in Chile. Emerg Infect Dis 2012; 18: 1370-1372.
30. Lopez-Urena D, Miranda E, Fonseca M et al. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama. J Med Microbiol 2013; 63: 322-324.
31. Wang P, Zhou Y, Wang Z et al. Identification of Clostridium difficile ribotype 027 for the first time in mainland China. Infect Control Hosp Epidemiol 2014; 35: 95-98.
32. Hubert B, Loo VG, Bourgault AM et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007; 44: 238-244.
33. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-2449.
34. Redelings MD, Sorvillo F, Mascola L et al. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13(suppl 9): 1417-1419.
35. Campbell RJ, Machesky K, Cibulskas-White K et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009; 30: 526-533.
36. Freeman J, Bauer MP, Baines SD et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23: 529-549.
37. Hensgens MP, Goorhuis A, Notermans DW, Van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 2009; 14(suppl 45): 19402.
38. He M, Miyajima F, Roberts P et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2012; 45: 109-113.
39. von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 1992; 233: 260-268.
40. Matamouros S, England P, Dupuy B. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 2007; 64: 1274-1288.
41. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995; 375: 500-503.
42. Just I, Wilm M, Selzer J et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995; 270: 13932-13936.
43. Taylor NS, Thorne GM, Barlett JG. Comparison of two toxins produced by Clostridium difficile. Infect Immun 1981; 34: 1036-1043.
44. Libby JM, Jornter BS, Wilkins TD. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun 1982; 36: 822-829.
45. Lyerly DM, Phelps CJ, Toth J, Wilkins TD. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun 1986; 54: 70-76.
46. Warny M, Ppin J, Fang A. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-1084.
47. Dupuy B, Govind R, Antunes A, Matamouros S. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol 2008; 57: 685-689.
48. Lanis JM, Barua S, Ballard JD. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog 2010; 6: e1001061.
49. Stabler RA, He M, Dawson L et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 2009; 10: R102.
50. Lanis JM, Heinlen LD, James JA, Ballard JD. Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. PLoS Pathog 2013; 9: e1003523.
51. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000; 186: 307-312.
52. Sundriyal A, Roberts AK, Ling R, McGlashan J, Shone CC, Acharya KR. Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile. Protein Expr Purif 2010; 74: 42-48.
53. Carter GP, Lyras D, Alles DL et al. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 2007; 189: 7290-7301.
54. Barbut F, Decre D, Lalande V et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005; 54: 181-185.
55. McEllistrem MC, Carman RJ, Gerding DN, Genheimer CW, Zheng L. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 2005; 40: 265-272.
56. Gerding DN, Muto CA, Owens RC. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008; 46: 43-49.
57. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007; 45: 992-998.
58. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-262.
59. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18: 247-263.
60. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005; 21: 44-50.
61. Burns DA, Heap JT, Minton NP. The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 2010; 16: 618-622.
62. Moore P, Kyne L, Martin A, Solomon K. Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure. J Med Microbiol 2013; 62: 1405-1413.
63. Heeg D, Burns DA, Cartman ST, Minton NP. Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts. PLoS One 2012; 7: e32381.
64. Oka K, Osaki T, Hanawa T et al. Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. J Clin Microbiol 2012; 50: 915-921.
65. Calabi E, Fairweather N. Patterns of sequence conservation in the S-layer proteins and related sequences in Clostridium difficile. J Bacteriol 2002; 184: 3886-3897.
66. Calabi E, Ward S, Wren B et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol 2001; 40: 1187-1199.
67. Cerquetti M, Molinari A, Sebastianelli A et al. Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog 2000; 28: 363-372.
68. Spigaglia P, Galeotti CL, Barbanti F, Scarselli M, Van Broeck J, Mastrantonio P. The LMW surface-layer proteins of Clostridium difficile PCR ribotypes 027 and 001 share common immunogenic properties. J Med Microbiol 2011; 60: 1168-1173.
69. Twine SM, Reid CW, Aubry A et al. Motility and flagellar glycosylation in Clostridium difficile. J Bacteriol 2009; 191: 7050-7062.
70. Drudy D, Kyne L, O'Mahony R, Fanning S. gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis 2007; 13: 504-505.
71. Dawson LF, Stabler RA, Wren BW. Assessing the role of p-cresol tolerance in Clostridium difficile. J Med Microbiol 2008; 57: 745-749.
72. Yokoyame MT, Carlson JR. Production of skatole and para-cresol by a rumen Lactobacillus sp. Appl Environ Microbiol 1981; 41: 71-76.
73. Sebaihia M, Wren BW, Mullany P et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 2006; 38: 779-786.
74. Howard SL, Jagannathan A, Soo EC et al. Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonization of chickens. Infect Immun 2009; 77: 2544-2556.
75. Spigaglia P, Carattoli A, Barbanti F, Mastrantonio P. Detection of gyrA and gyrB mutations in Clostridium difficile isolates by real-time PCR. Mol Cell Probes 2010; 24: 61-67.
76. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-2441.
77. Kim J, Pai H, Seo MR, Kang JO. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital. J Korean Med Sci 2011; 26: 1258-1264.
78. Fenner L, Widmer AF, Stranden A. First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in Switzerland. Clin Microbiol Infect 2008; 14: 514-515.
79. Muto CA, Pokrywka M, Shutt K et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005; 26: 273-280.
80. Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363-372.
81. Nyc O, Pituch H, Matejkova J, Obuch-Woszczatynski P, Kuijper EJ. Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet 2011; 377: 1407.
82. Brazier JS. Clostridium difficile: the anaerobe that made the grade. Anaerobe 2012; 18: 197-199.
83. Valiente E, Dawson LF, Cairns MD, Stabler RA, Wren BW. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J Med Microbiol 2012; 61: 49-56.
84. Parkhill J, Wren BW. Bacterial epidemiology and biology-lessons from genome sequencing. Genome Biol 2011; 12: 230.
85. Chin CS, Sorenson J, Harris JB et al. The origin of the Haitian cholera outbreak strain. N Engl J Med 2011; 364: 33-42.
86. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-474.
87. Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis 2012; 55: 65-70.